Antidepressant Use in Late Pregnancy

Buist A . Managing depression in pregnancy. Aust Fam Physician 2000; 29 (7):663–7

Murray CJ Lopez AD . Evidence-based health policy — lessons from the Global Burden of Disease Study . Science 1996;274(5288):740–3

Weissman MM Bland R Joyce PR Sex differences in rates of depression: cross-national perspectives. J Affect Disord 1993; 29(2–3):77–84

Kalra S Sarkar M Einarson A . Safety of antidepressants in pregnancy. Expert Opin Drug Saf 2005; 4 (2):273–84

Chambers CD Johnson KA Dick LM Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996; 335 (14):1010–5

Costei AM Kozer E Ho T Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med 2002; 156 (11):1129–32

Hendrick V Smith LM Suri R Birth outcomes after prenatal exposure to antidepressant medication. Am J Obstet Gynecol 2003; 188 (3):812–5

Oberlander TF Misri S Fitzgerald CE Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry 2004; 65 (2):230–7

Kallen B . Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med 2004; 158 (4):312–6

Health Canada advises of potential adverse effects of SSRIs and other antidepressants on newborns [advisory]. Health Canada Online 2004(Aug 9);2004–44. Available: www.hc-sc.gc.ca/english/protection/warnings/2004/2004_44.htm (accessed November 21, 2005)

Bonari L Pinto N Ahn E Perinatal risks of untreated depression during pregnancy. Can J Psychiatry 2004; 49 (11):726–35

Beck CT . Revision of the postpartum depression predictors inventory. J Obstet Gynecol Neonatal Nurs 2002; 31 (4):394–402

Einarson A Selby P Koren G . Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling. J Psychiatry Neurosci 2001; 26 (1):44–8

Rosenbaum JF Zajecka J . Clinical management of antidepressant discontinuation. J Clin Psychiatry 1997; 58(Suppl 7):37–40